3.48
3.48 (0%)
As of Feb 14, 2025
Rapid Micro Biosystems, Inc. [RPID]
Source:
Company Overview
Rapid Micro Biosystems, Inc. is an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics and cell and gene therapies, vaccines, and sterile injectables.
| Country | United States |
| Headquarters | lowell, massachusetts |
| Phone Number | 978-349-3200 |
| Industry | |
| CEO | Robert Spignesi |
| Website | rapidmicrobio.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $28.1 |
| Operating Profit | $-49.9 |
| Net Income | $-46.9 |
| Net Cash | $-7.3 |
Profit Ratios
| Gross Margin | $28.1 |
| Operating Margin | -178 |
| Profit as % of Revenues | -59.8% |
| Profit as % of Assets | -38.8% |
| Profit as % of Stockholder Equity | -62.2% |
Management Effectiveness
| Return on Equity | -62.2% |
| Return on Assets | -47.8% |
| Turnover Ratio | 23.2% |
| EBITA | $-49.9 |
Balance Sheet and Cash Flow Measures
| Total Assets | $98.2 |
| Total Liabilities | $22.8 |
| Operating Cash Flow | $-44.2 |
| Investing Cash Flow | $36.7 |
| Financing Cash Flow | $0.2 |
